Advanced Oxygen Technologies Inc

AOXY is U.S.-listed and identified in the provided information as based in the United States, but the operating disclosures reference currency fluctuations and foreign currency translation effects, implying some exposure outside the U.S. The filings do not provide an authoritative revenue-by-geography table or country-level revenue breakdown in the excerpts provided. As a result, geographic concentration risk is best inferred as being driven by where ANV’s leased assets and tenants are located and by any non-USD denominated balances that create translation impacts. Any future acquisition could materially change the geographic footprint depending on the target’s operations.

AOXY’s business risk profile is heavily influenced by its small revenue base and reliance on lease revenues from the ANV subsidiary, making results sensitive to tenant/lessee retention, renewals, and any asset-level disruptions. Management explicitly notes expected difficulty in financing growth or acquisitions, creating execution risk around the stated M&A strategy and potential dilution or unfavorable borrowing terms. The company also shows exposure to foreign currency translation and transaction effects, which can create volatility in reported results even if underlying operations are stable. Typical real-estate/leasing risks also apply, including counterparty credit risk, asset impairment risk, and sensitivity to interest rates and refinancing conditions.